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1. Introduction 
The main biological activities of interferon are the 
capacity to confer on cells resistance to virus infec- 
tion, and the inhibition of growth of malignant cells 
in vivo and in vitro [l-l]. In addition, a variety of 
other effects have been described [ 11. We were 
attracted to the subject by a report describing an 
increase in the buoyant density of the plasma mem- 
brane of mouse L cells after 18 h treatment with 
mouse interferon [5]. We have found that the fuso- 
genie properties of Newcastle disease virus (NDV) and 
Sendai virus are selectively inhibited by treatment 
with free iodine [6]. The fusogenic property of these 
viruses is their capacity to induce haemolysis and 
fusion of cells, and includes virus entry (infection) by 
fusion of the virus envelope and the cell membrane 
[7]. We went on to show that there was a direct cor- 
relation between the inhibition of haemolysis and the 
degree of saturation of the fatty acids of the virus by 
iodine [ 81. We concluded that the fusogenic proper- 
ties of these viruses are dependent on the fluidity of 
the virus membrane. The saturation of fatty acids 
decreases the fluidity and mobility of the biological 
membranes [9]. This concept was also supported by 
the finding that virulent strains of NDV, which are 
more fusogenic than the avirulent ones, induce a rela- 
tive increase in unsaturated fatty acids (UFA) in 
infected cells as well as in the virions released [lo]. 
Here, we show that interferons are involved in the 
metabolism of the fatty acids of infected cells, espe- 
cially in the modification of the degree of saturation 
of the 18 carbon fatty acids (Cl 8 FA). 
2. Materials and methods 
Human fibroblasts (MRCS) were obtained from 
Porton Down and used at the 27th passage. Primary 
ElsevierfNorth-Holland Biomedical Press 
bovine kidney cells were kindly supplied by Mr D. 
Luther, ARC Institute for Research on Animal 
Diseases, Compton, Newbury, Berks. 
The cells were grown at 37°C on medium 199 
(Flow Labs.), supplemented with 7.5% fetal calf 
serum and 2 mM L-glutamine and containing anti- 
biotics penicillin and streptomycin at 100 IU and 
/*g/ml. Experiments were performed in 25 cm2 tissue 
culture flasks with the cells at 75% confluence. 
Human leucocyte interferon (Hu IFN-cu (Ly)), and 
quantitated antiserum to this interferon, was kindly 
supplied by Dr C. Fantes, Wellcome Research Labo- 
ratories, Beckenham, Kent. Human fibroblast inter- 
feron (Hu IFN-fl), was kindly supplied by Dr T. 
Cartwright, Searle Laboratories, High Wycombe, 
Bucks, Interferons were stored frozen at -2O’C in 
PBS containing 1% serum albumen. 
Time-dependent kinetic and dose-response exper- 
iments: The growth medium was removed and the 
cell sheet washed with PBS. Cells were incubated for 
1 h at 37°C overlaid with serum-free medium contain- 
ing the relevant concentration of interferon. Unad- 
sorbed interferon was washed away after this time 
and the cells incubated at 37°C for the required time, 
overlaid with serum-free medium. Harvesting of the 
cells was accomplished by freezing the flasks at 
-20°C and the cells stored at this temperature until 
required for lipid extraction. 
Antibody neutralisation tests: interferon was 
incubated with a 10 X excess of antibody at room 
temperature for 2 h. After this time the equivalent of 
1000 units/ml interferon of this mixture, in serum- 
free medium, was applied to the cells for 1 h 
(100 units/ml in the case of Hu IFN-a on PBKC). The 
cell sheet was then washed and the medium replaced 
with serum-free medium for a subsequent 12 h incu- 
bation, when the cells were frozen for fatty acid 
extraction. 
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Interferon controls were similarly set up, without 
pretreatment of the interferon, and antibody con- 
trols, without interferon. 
Lipid extraction and fatty acid identification: cells 
were disrupted by 3 cycles of freezing and thawing. 
The total lipids were extracted and the fatty acid 
methyl esters obtained as in [8]. 
The fatty acid methyl esters were separated by 
gas-liquid chromatography (GLC) on 3% OVl on 
100/l 20 Gas Chrom. Q. Matched 1.4 m X 4 mm i.d. 
glass columns (Pye Unicam) were used with a tem- 
perature programme comprising a 4 min isothermal 
period at 160°C followed by a programmed rise of 
4”C/min to 240°C on a Pye Unicam series 204 chro- 
matograph. Nitrogen was used as the carrier gas at a 
flow rate of 30 ml/min and detection of the fatty 
acids was by flame ionisation. Identification of the 
fatty acids was by comparison of retention times and 
co-chromatography with authentic fatty acid methyl 
esters (Appl. Sci. Labs., Sigma). 
3. Results and discussion 
The human leucocyte (Hu INF-ol (Le)), lympho- 
blast (Hu INF-a: (Ly)), and fibroblast (Hu INF-/3) 
interferons were used for treatment of human fibro- 
blast (MRC-5) cells and also primary bovine kidney 
cells (PBKC) [ 111. Chick chorioallantoic interferon 
induced by Sendai virus was used for treatment of 
chick fibroblasts. After extraction of the interferon- 
treated cell and GLC separation of the fatty acids, we 
chose the ratio of the peak heights of the 18 carbon 
saturated fatty acid (Cl 8s) to the 18 carbon unsatu- 
rated fatty acids (Cl 8~) as a marker for the effects of 
the interferons. This ratio was used because the changes 
in the 18 carbons were consistent and reproducible, in 
contrast to the other major group, the 16 carbon fatty 
acids. In addition, the 18 carbon fatty acids represent 
>60% of all the fatty acids extractable from the cell. 
Moreover, changes in saturation of FA are reflected 
in abrupt changes of melting points, with a conse- 
quent change of buoyant density and fluidity in the 
constituent lipids. In the GLC programme which we 
are using the unsaturated Cl 8 FA are grouped in one 
peak and stearic acid in another. 
In fig.1 we show the time-dependent kinetics of 
the Cl 8s:ClSu ratio in human fibroblast and PBKC 
after treatment with human interferons. There is a 
marked relative increase in stearic acid (Cl 8s) rising 
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Fig.1. Kinetics of the effect of interferon on the C18s:ClBu 
ratio in MRCS and PBKC cells: MRCS cells trcatcd with 
1000 units/ml Hu INF-or (Ly) (a); PBKC treated with 
100 units/ml Hu 1NF-o (Ly) (0); MRC5 cells treated with 
100 units/ml Hu INF-fl (*). Open symbols represent untreated 
controls and the broken line represents the control levels. 
to a maximum at 10-l 2 h, followed by a return to 
control values at 20-22 h. However, there is a sub- 
sequent relative increase in the unsaturated Cl 8 fatty 
acids, reaching a maximum at 24-30 h with a gradual 
return to control values by 72 h. This effect was 
achieved with (Hu INF) concentrations >lOO units/ml 
in human fibroblasts, and in primary bovine kidney 
cells with Hu IFN-(Y at >lO units/ml but not with 
Hu IFN-P. The higher sensitivity of PBKC to Hu IFN-a 
and the lack of effect with Hu IFN-fl in PBKC, are in 
agreement with the results on the higher sensitivity of 
PBKC to Hu IFN-cr as demonstrated by antiviral 
activity [ 121. Incubating the cells in the continued 
presence of interferon, rather than washing away 
unadsorbed material after 1 h (not shown), produced 
similar results to those described above, indicating 
that it is the initial interferon concentration present 
which determines the reaction of the cell, rather than 
Volume 126, number 2 FEBS LETTERS April 1981 
Table 1 
Antibody neutralisation: the effect on the C18s:C18u ratio of Hu 1FN-o and Hu IFNQ on MRCS cells and PBKC, together with 
the effect of pre-treatment of these interferons with Hu 1FN-e antiserum before application to the ceIi 
__ - . .._._ 
MRC5 PBKC 
Control Hu 1FN-o (Ly) Hu IFN$ .Control Hu IFNiu (Ly) Hu IFN-@ 
-Ab +Ab -Ab +Ab -Ab +Ab -Ab +Ab -Ab +Ab -Ab +Ab 
Cl8s:Cl8u 1.23 1.30 3.21 1.28 2.63 2.03 1.10 1.07 2.98 1.15 1.07 1.12 
% Inhibition - - - 97.5 - 42.9 - - - 97.3 - 0 
_____.._ 
the continued action of interferon. Using crude chick 
interferon on chick libroblasts a similar kinetic 
response in the Cl 8s:C18u ratio was obtained (not 
shown), but the changes were smaller. 
The specific nature of the effects of interferons on 
the Cl 8s:C18u ratio is also shown by the studies on 
inhibition by antibody (table 1). Antibody to 
Hu INF-a (Ly) inhibited almost completely the effects 
of Hu INF-CY (Ly) but only partially the effects of 
Hu INF-@. These findings are in agreement with the 
studies in which similar results were obtained using 
virus inhibition as an interferon marker [ II-141. 
The dose-dependent response effects of interferon 
on the Cl 8s:Cl8u are shown in fig.2. After treatment 
for 12 h the Cl 8s:CI 8u ratio increases with the 
higher concentration of interferon. However, as 
expected, at 24 h the depression in the ratio is bigger 
with higher doses. A similar dose-dependent response 
was obtained with Hu IFN$ on MRC5 cells. It is 
interesting to note that the peak ratios of Cl6 fatty 
acids were not changed and did not follow the 
changes in the Cl 8, which raises the possibility that 
interferon might act on the Cl 8 FA only. 
These results suggest hat one effect of interferon 
on the metabolism of the cell is the modification of 
the saturation of the fatty acids. The increase in satu- 
ration of the fatty acids would lead to integration 
into the cell membranes of lipids with higher buoyant 
densities. Mouse L cells, treated with mouse inter- 
feron for 18 h show an increase in the buoyant den- 
sity of plasma mel~branes, with no change in the 
membrane mass [S]. An increase in the Cl 8s leads to 
a decrease of membrane fluidity, but conversely an 
increase in Cl 8 u leads to a greater membrane fluidity 
[8,9]. Some of the biological activities of interferon 
could be explained in terms of the increase and 
decrease in Cl 8s:C18u ratio. Reduced membrane 
fluidity could result in inhibition of cell division, fail- 
ure of virus maturation and release of enveloped 
viruses [ 14-161 and also inhibition of virus replica- 
tion by inhibition of enzymatic activity [ 171. 
The rebound effect, the relative increase in Cl 8u 
beyond the control values (fig.1) with higher concen- 
trations of interferon, could explain the phenomenon 
of refractory effect to interferon [l&21]. Higher 
concentrations of interferons induced in tissue cul- 
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Fig.2. Dosedependent C18s:C18u ratio after treatment for 
12 h and 24 h. PBKC treated with Hu INF-cu (Ly). The 
broken lines represent he untreated control cell values. 
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ture a state of refractoriness to further production of 
interferon at times coincidental with the depression 
in the Cl 8s:C18u ratio [ 191. Also, a coincidental 
decreased inhibition of virus replication has been 
described [ 191. It is interesting that the response of 
macrophages to interferon was reported to the 
biphasic. The initial inhibition of phagocytic activity 
of 12-l 8 h was followed by enhancement after 
24 h [22]. 
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